Zoltan Herold (Zoltán Herold)

ResearcherID Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 34

Top Venues

Cancers

International journal of molecular sciences

PloS one

Biomedicines

Semmelweis Egyetem Doktori Iskola (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Semmelweis Egyetem Doktori Iskola Sep 01 2016

Hungary

PHD :: Doctoral School of Clinical Medicine

Szent Istvan Egyetem Allatorvos-tudomanyi Kar Sep 01 2014 - Jun 01 2016

Hungary

MSC

Szent Istvan Egyetem Allatorvos-tudomanyi Kar Sep 01 2011 - Aug 31 2014

Hungary

BSC

Publications

Ivan Panczel, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso, Hans Jürgen Schlitt, Magdolna Dank, Attila Marcell Szasz, Zoltan Herold
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International journal of molecular sciences 25 (13) (2024)
Gábor Nyirő, Bálint Kende Szeredás, Ábel Decmann, Zoltan Herold, Bálint Vékony, Katalin Borka, Katalin Dezső, Attila Zalatnai, Ilona Kovalszky, Péter Igaz
miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors. Cancers 16 (14) (2024)
Gyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold, Magdolna Dank
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. Biomedicines 12 (3) (2024)
Gábor Nyirő, Bálint Kende Szeredás, Ábel Decmann, Zoltan Herold, Bálint Vékony, Katalin Borka, Katalin Dezső, Attila Zalatnai, Ilona Kovalszky, Péter Igaz
miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors. Cancers 16 (14) (2024)
Gyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold, Magdolna Dank
Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. Biomedicines 12 (3) (2024)
Ivan Panczel, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso, Hans Jürgen Schlitt, Magdolna Dank, Attila Marcell Szasz, Zoltan Herold
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International journal of molecular sciences 25 (13) (2024)
Ivan Panczel, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso, Hans Jürgen Schlitt, Magdolna Dank, Attila Marcell Szasz, Zoltan Herold
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International journal of molecular sciences 25 (13) (2024)
Gábor Nyirő, Bálint Kende Szeredás, Ábel Decmann, Zoltan Herold, Bálint Vékony, Katalin Borka, Katalin Dezső, Attila Zalatnai, Ilona Kovalszky, Péter Igaz
miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors. Cancers 16 (14) (2024)
Mihály Horváth, Zoltan Herold, Marianna Küstel, László Tamás, Péter Prekopp, Anikó Somogyi, Anita Gáborján
Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus. PloS one 18 (5) (2023)
Beáta Szeitz, Tibor Glasz, Zoltan Herold, Gábor Tóth, Mirjam Balbisi, János Fillinger, Szabolcs Horváth, Réka Mohácsi, Ho Jeong Kwon, Judit Moldvay, Lilla Turiák, Attila Marcell Szász
Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. International journal of molecular sciences 24 (14) (2023)
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 15 (4) (2023)
Andras Jozsef Barna, Zoltan Herold, Miklos Acs, Sandor Bazsa, Jozsef Gajdacsi, Tamas Marton Garay, Magdolna Herold, Lilla Madaras, Dorottya Muhl, Akos Nagy, Attila Marcell Szasz, Magdolna Dank
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer. International journal of molecular sciences 24 (18) (2023)
Dorina Supák, Balázs Mészáros, Balázs Turi, Zoltan Herold, Zoltán Kukor, Sándor Valent
Predicting Potentially Fatal COVID-19 Disease in Pregnant Patients Using the Neutrophil-to-Lymphocyte Ratio (NLR). Journal of clinical medicine 12 (21) (2023)
Attila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, Magdolna Herold, Zoltan Herold, Donatella Sarti, Magdolna Dank
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas. Cancers 15 (3) (2023)
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 15 (4) (2023)
Mihály Horváth, Zoltan Herold, Marianna Küstel, László Tamás, Péter Prekopp, Anikó Somogyi, Anita Gáborján
Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus. PloS one 18 (5) (2023)
Attila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, Magdolna Herold, Zoltan Herold, Donatella Sarti, Magdolna Dank
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas. Cancers 15 (3) (2023)
Mihály Horváth, Zoltan Herold, Marianna Küstel, László Tamás, Péter Prekopp, Anikó Somogyi, Anita Gáborján
Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus. PloS one 18 (5) (2023)
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 15 (4) (2023)
Magdolna Dank, Dorottya Mühl, Annamária Pölhös, Renata Csanda, Magdolna Herold, Attila Kristof Kovacs, Lilla Madaras, Janina Kulka, Timea Palhazy, Anna-Maria Tokes, Monika Toth, Mihaly Ujhelyi, Attila Marcell Szasz, Zoltan Herold
The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience. Genes 14 (9) (2023)
Dorottya Mühl, Magdolna Herold, Zoltan Herold, Lilla Hornyák, Attila Marcell Szasz, Magdolna Dank
Longitudinal Analysis of 1α,25-dihidroxyvitamin D 3 and Homocysteine Changes in Colorectal Cancer. Cancers 14 (3) (2022)
Zoltan Herold, Miklos Acs, Attila Marcell Szasz, Katalin Olasz, Jana Hussong, Max Mayr, Magdolna Dank, Pompiliu Piso
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts. Cancers 14 (16) (2022)
Emese Irma Ágoston, Balazs Acs, Zoltan Herold, Krisztina Fekete, Janina Kulka, Akos Nagy, Dorottya Mühl, Reka Mohacsi, Magdolna Dank, Tamas Garay, Laszlo Harsanyi, Balazs Győrffy, Attila Marcell Szasz
Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation. Genes 13 (4) (2022)
Márton Doleschall, Ottó Darvasi, Zoltan Herold, Zoltán Doleschall, Gábor Nyirő, Anikó Somogyi, Péter Igaz, Attila Patócs
Quantitative PCR from human genomic DNA: The determination of gene copy numbers for congenital adrenal hyperplasia and RCCX copy number variation. PloS one 17 (12) (2022)
Miklos Acs, Zoltan Herold, Attila Marcell Szasz, Max Mayr, Sebastian Häusler, Pompiliu Piso
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Cancers 14 (14) (2022)
Magdolna Dank, Dorottya Mühl, Magdolna Herold, Lilla Hornyák, Attila Marcell Szasz, Zoltan Herold
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer? Journal of clinical medicine 11 (16) (2022)
Gyorgy Herczeg, Anikó Somogyi, Magdolna Herold, Agnes Fodor, Klara Rosta, Magdolna Dank, Zsolt Lang, Zoltan Herold
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer? Open medicine (Warsaw, Poland) 17 (1) (2022)
Péter István Turai, Zoltan Herold, Gábor Nyirő, Katalin Borka, Tamás Micsik, Judit Tőke, Nikolette Szücs, Miklos Toth, Attila Patocs, Péter Igaz
Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence. Cancers 14 (4) (2022)
Flora Greta Petenyi, Tamas Garay, Dorottya Muhl, Blanka Izso, Adam Karaszi, Erika Borbenyi, Magdolna Herold, Zoltan Herold, Attila Marcell Szasz, Magdolna Dank
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study. Diseases (Basel, Switzerland) 9 (4) (2021)
Zoltan Herold, Magdolna Herold, Klara Rosta, Marton Doleschall, Aniko Somogyi
Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment. Diabetology & metabolic syndrome 12 (2020)
Zoltan Herold, Magdolna Herold, Peter Nagy, Attila Patocs, Márton Doleschall, Anikó Somogyi
Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis. Journal of diabetes investigation 11 (4) (2020)
Zsuzsanna Elek, Zsolt Rónai, Gergely Keszler, László Harsányi, Endre Kontsek, Zoltan Herold, Magdolna Herold, Anikó Somogyi, Zsófia Bánlaki
Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients. Life (Basel, Switzerland) 10 (9) (2020)
Zoltan Herold, Magdolna Dank, Magdolna Herold, Peter Nagy, Klara Rosta, Aniko Somogyi
Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis. Cancers 13 (1) (2020)
Zoltan Herold, Andrea Uhlyarik, Magdolna Herold, Peter Nagy, Gergely Denes Huszty, Klara Rosta, Márton Doleschall, Anikó Somogyi
Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetes. Endokrynologia Polska 71 (5) (2020)

Zoltan Herold.css-eqlu8i{font-size:small;padding-left:4px;} (Zoltán Herold)

Publication Activity (10 Years)

Top Topics

Top Venues

Zoltan Herold (Zoltán Herold)